BREAKING: Oxford Uni vaccine appears safe and trains immune system, early trials show
Professor Sarah Gilbert, of the University of Oxford, said: ‘There is still much work to be done before we can confirm if our vaccine will help manage the Covid-19 pandemic, but these early results hold promise.
A volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the UK to test a potential vaccine, led by Oxford University He tweeted: ‘We have already ordered 100 million doses of this vaccine, should it succeed.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Russia claims to have signed Covid-19 vaccine deal with Oxford UniKirill Dmitriev, head of Russia's sovereign wealth fund, pictured right said Moscow has signed a deal to produce a Covid-19 vaccine with Oxford University.
Read more »
Russia claims to have signed Covid-19 vaccine deal with Oxford UniKirill Dmitriev, head of Russia's sovereign wealth fund, pictured right said Moscow has signed a deal to produce a Covid-19 vaccine with Oxford University.
Read more »
Russia claims to have signed Covid-19 vaccine deal with Oxford UniKirill Dmitriev, head of Russia's sovereign wealth fund, pictured right said Moscow has signed a deal to produce a Covid-19 vaccine with Oxford University.
Read more »
Oxford coronavirus vaccine is 'safe' and produces immune reaction, first study results showVaccine causes few side effects and trains immune system to produce antibodies and white blood cells capable of fighting virus
Read more »
Oxford coronavirus vaccine is 'safe' and produces immune reaction, first study results showThe coronavirus vaccine candidate being developed by Astrazeneca and Oxford University induces a strong immune response and is safe to use in humans, according to preliminary trial results. The early
Read more »
UK coronavirus live: Oxford University vaccine safe and induces immune reaction, early results showUK secures agreement for 30m doses of drug being developed by BioNTech and Pfizer and a deal in principle for 60m doses of one by Valneva
Read more »